neurodAIgnostics
neurodAIgnostics uses AI to revolutionize cognitive tests.
neurodAIgnostics AG is a Swiss MedTech spin-off pioneering AI-powered cognitive assessments. Our platform automates the scoring and reporting of established neuropsychological tests, reducing assessment time from hours to seconds while improving accuracy and efficiency. Built on deep learning, digital pen, and speech analysis technologies, our applications integrate seamlessly into clinical workflows. We empower clinicians to deliver faster, more precise diagnoses, scale capacity, and unlock new diagnostic insights.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
11.09.2025
The Future of Health Grant sets foot in Europe (startupticker.ch)
10.09.2025
15.08.2025
4 Swiss & 1 Austrian pilot running
04.08.2025
Incorporation of neurodAIgnostics AG
01.06.2025
collaboration with Comerge AG for FDA approval
15.05.2025
Winner: Zühlke Product Scale-Up Coaching
No Jobs
No videos and documents
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
neurodAIgnostics
neurodAIgnostics uses AI to revolutionize cognitive tests.
Headquarter:
Zürich
Foundation Date:
August 2025
Technology:
- Medtech
Sectors:
- Digital Health
- Diagnostics
- Machine Learning / AI
- Medtech
- Neurology
Support received
